DFW invests in Lotus Clinical Research

DFW Capital Partners has made an investment in Pasadena, California-based Lotus Clinical Research LLC, a CRO, clinical research site and regulatory consulting firm focused in the pain therapeutic area. No financial terms were disclosed. In addition to the investment, Lotus has named Jeffrey Kinell and Kurt Brykman to its board of directors.